Identification |
Name: | 3,4,5-Piperidinetriol,1-butyl-2-(hydroxymethyl)-, (2R,3R,4R,5S)- |
Synonyms: | 3,4,5-Piperidinetriol,1-butyl-2-(hydroxymethyl)-, [2R-(2a,3b,4a,5b)]-; Miglustat; N-Butyl-1-deoxynojirimycin; N-Butyldeoxynojirimycin;N-Butylmoranoline; NB-DNJ; OGT 918; SC 48334; Zavesca |
CAS: | 72599-27-0 |
Molecular Formula: | C10H21 N O4 |
Molecular Weight: | 219.278 |
InChI: | InChI=1/C10H21NO4.ClH/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12;/h7-10,12-15H,2-6H2,1H3;1H/t7-,8+,9-,10-;/m1./s1 |
Molecular Structure: |
|
Properties |
Density: | 1.234 g/cm3 |
Biological Activity: | Orally active α -glucosidase I and II and ceramide-specific glycosyltransferase inhibitor. Rescues trafficking-deficient F508del-CTFR in human airway epithelial cells via inhibition of ER α -glucosidases I and II. Also has broad spectrum antiviral activity. |
Storage Temperature: | 2-8°C |
Safety Data |
|
|